期刊
CURRENT OPINION IN CHEMICAL BIOLOGY
卷 66, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2021.102106
关键词
-
By incorporating latent bioreactive amino acids into proteins through genetic code expansion, selective covalent linkages can be generated, enabling the development of covalent protein drugs with improved therapeutic potential.
As natural proteins generally do not bind targets in a covalent mode, the therapeutic potential of covalent protein drugs remains largely unexplored. Recently, latent bioreactive amino acids have been incorporated into proteins through genetic code expansion, which selectively react with nearby natural residues via proximity-enabled reactivity, generating diverse covalent linkages for proteins in vitro and in cells. These new covalent linkages provide novel avenues for protein research and engineering. In addition, a general platform technology, proximity-enabled reactive therapeutics (PERx), has been established for the development of covalent protein drugs. The first covalent protein drug demonstrates advantageous features in cancer immunotherapy in mice. Selective introduction of covalent bonds into proteins will advance biological studies, synthetic biology, and biotherapeutics with the power of biocompatible covalent chemistries.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据